Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Random thoughts

Hope all is well first of all.. So your take regarding RG's statements wrt the Js...

I will not, in the limited context of this letter, recount all the information contained in our April 9, 2008 earnings release, which fully reflects the financial results of all transactions announced prior to the end of January 2008

all licensees to date have chosen lump sum front-end buy-outs

"On December 18, 2007 all remaining parties to the litigation announced that a resolution was reached in the patent infringement lawsuits. The terms of the settlement included the grant by TPL of rights under the Moore Microprocessor Patent Portfolio toNEC Electronics America, Toshiba, Matsushita and JVC and their respective subsidiaries in the form of license agreements. The parties have agreed that the details of the settlement are confidential."

is... ?

Also, how, or why, if TPL is asking for large payments from the T3, do they expect them to agree to those expensive licenses when all public evidence & statements points to what the Js paid was in fact not extrordinary large sums? If the NDA & CC (as well as TPL's stated business model) prevent TPL & PTSC from sharing this info with us, how can they prove to the T3 that they should in deed pay what TPL is asking?

Thanks Fut... your opinion is respected & valued

Share
New Message
Please login to post a reply